News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Kauffman Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Disposed/sold 37,000 options to buy
@ $9.39, valued at
$347.4k
Granted 37,000 options to buy
@ $0
Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Granted 18,500 options to buy
@ $0
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/02/2023 |
4
| Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 5,900 shares
@ $0
Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
| 05/16/2023 |
4
| Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 62,500 options to buy
@ $0.42, valued at
$26.3k
|
|
| 12/20/2022 |
4/A
| Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 62,500 options to buy
@ $1.07, valued at
$66.9k
|
|
| 06/24/2022 |
4
| Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 62,500 options to buy
@ $1.11, valued at
$69.4k
|
|
| 06/17/2022 |
4
| Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 26,000 options to buy
@ $4.8, valued at
$124.8k
|
|
| 06/03/2022 |
4
| Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 18,500 options to buy
@ $11.49, valued at
$212.6k
|
|
| 03/02/2022 |
4
| Kauffman Michael (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 21,000 shares
@ $0
Sold 6,226 shares
@ $10.2375, valued at
$63.7k
Sold 6,226 shares
@ $10.2375, valued at
$63.7k
Granted 27,000 options to buy
@ $10.33, valued at
$278.9k
|
|
| 02/22/2022 |
4
| Kauffman Michael (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 9,079 shares
@ $12.1234, valued at
$110.1k
Sold 9,088 shares
@ $12.1234, valued at
$110.2k
|
|
| 02/11/2022 |
SC 13G/A
| Kauffman Michael reports a 5.2% stake in KARYOPHARM THERAPEUTICS INC. |
| 02/09/2022 |
4
| Kauffman Michael (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 6,764 shares
@ $9.862, valued at
$66.7k
Sold 6,707 shares
@ $9.862, valued at
$66.1k
|
|
| 01/05/2022 |
4
| Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 5,000 shares
@ $16.45, valued at
$82.3k
Exercised 5,000 options to buy
@ $5.91, valued at
$29.6k
|
|
| 11/18/2021 |
4
| Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 37,000 options to buy
@ $9.39, valued at
$347.4k
|
|
| 11/18/2021 |
3
| Kauffman Michael (Director) has filed a Form 3 on Adicet Bio, Inc. |
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.16, valued at
$104k
|
|
| 03/23/2021 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 4,000 shares
@ $12.3882, valued at
$49.6k
|
|
| 03/01/2021 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 57,200 shares
@ $0
Granted 57,200 shares
@ $0
Granted 153,500 options to buy
@ $14.56, valued at
$2.2M
Granted 153,500 options to buy
@ $14.56, valued at
$2.2M
|
|
| 02/22/2021 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 9,495 shares
@ $14.8312, valued at
$140.8k
Sold 9,495 shares
@ $14.8312, valued at
$140.8k
|
|
| 02/17/2021 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 6,601 shares
@ $15.519, valued at
$102.4k
Sold 6,642 shares
@ $15.519, valued at
$103.1k
Exercised 21,800 restricted stock units
@ $0
Exercised 21,800 restricted stock units
@ $0 |
|
| 02/16/2021 |
SC 13G/A
| Kauffman Michael reports a 5.5% stake in KARYOPHARM THERAPEUTICS INC. |
| 02/09/2021 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Exercised 14,300 restricted stock units
@ $0
Exercised 14,300 restricted stock units
@ $0 |
|
| 10/14/2020 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,500 shares
@ $14.891, valued at
$111.7k
Exercised 1,424 options to buy
@ $0.033, valued at
$47
Exercised 6,076 options to buy
@ $0.033, valued at
$200.5 |
|
| 08/18/2020 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 1,477 shares
@ $15, valued at
$22.2k
Exercised 1,477 options to buy
@ $0.033, valued at
$48.7 |
|
| 07/17/2020 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,500 shares
@ $19.4297, valued at
$145.7k
Exercised 7,500 options to buy
@ $0.033, valued at
$247.5 |
|
| 07/13/2020 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,200 shares
@ $18.976, valued at
$136.6k
Sold 300 shares
@ $19.7067, valued at
$5.9k
Sold 7,500 shares
@ $19.5316, valued at
$146.5k
Exercised 7,500 options to buy
@ $4.752, valued at
$35.6k
Exercised 7,500 options to buy
@ $4.752, valued at
$35.6k
|
|
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,500 shares
@ $20, valued at
$150k
Exercised 7,500 options to buy
@ $0.033, valued at
$247.5 |
|
| 06/18/2020 |
4
| Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.77, valued at
$44.3k
|
|
| 06/17/2020 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,143 shares
@ $16.3791, valued at
$117k
Sold 357 shares
@ $16.2, valued at
$5.8k
Exercised 7,143 options to buy
@ $0.033, valued at
$235.7
Exercised 357 options to buy
@ $0.033, valued at
$11.8 |
|
| 06/11/2020 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,500 shares
@ $18.1259, valued at
$135.9k
Sold 7,500 shares
@ $18.4994, valued at
$138.7k
Exercised 7,500 options to buy
@ $4.752, valued at
$35.6k
Exercised 7,500 options to buy
@ $4.752, valued at
$35.6k
|
|
| 05/19/2020 |
4
| Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,500 shares
@ $18.6454, valued at
$139.8k
Sold 7,500 shares
@ $20, valued at
$150k
Exercised 7,500 options to buy
@ $0.033, valued at
$247.5
Exercised 7,500 options to buy
@ $0.033, valued at
$247.5 |
|
|
|
|